- Telehealth Visits
Yvonne W. Wu, MD, MPH
Pediatric NeurologyYvonne W. Wu, MD, MPH
Pediatric Neurology- Telehealth Visits
On this page
About me
Dr. Yvonne Wu is a child neurologist and epidemiologist with expertise in newborn brain injury and cerebral palsy. Her research focuses on developing new strategies to prevent cerebral palsy.
Wu obtained a medical degree from Harvard Medical School. She then completed residencies in pediatrics and child neurology at UCSF. She also earned a master's in public health with a focus on epidemiology at University of California, Berkeley.
Wu serves on the editorial boards of the medical journals Pediatric Neurology and Journal of Child Neurology, and was an elected council member for the Society for Pediatric Research. She has published over 77 papers in medical journals such as Journal of the American Medical Association, The New England Journal of Medicine and Pediatrics.
Wu belongs to the American Pediatric Society/Society for Pediatric Research and the Child Neurology Society. She is a professor of neurology and pediatrics at UCSF. She speaks Mandarin and Spanish.
Education
Board Certification
- Neurology w/ Special Qualification in Child Neurology - General, American Board of Medical Specialties
Residency
- Neurology, University of CA at San Francisco - Neurology GME
Internship
- Pediatrics, University of CA San Francisco/Pediatric Residency
School
- MD, Harvard Medical School
Care Keywords
Services
- Pediatric Neurology
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.